These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 2770562)
1. Susceptibility of Mycobacterium avium and Mycobacterium intracellulare to various antibacterial drugs. Tomioka H; Sato K; Saito H; Yamada Y Microbiol Immunol; 1989; 33(6):509-14. PubMed ID: 2770562 [TBL] [Abstract][Full Text] [Related]
2. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs]. Tomioka H; Sato K; Saito H Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates. Huang CC; Wu MF; Chen HC; Huang WC J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770 [TBL] [Abstract][Full Text] [Related]
4. Difference in drug susceptibility distribution and clinical characteristics between Wang W; Yang J; Wu X; Wan B; Wang H; Yu F; Guo Y J Med Microbiol; 2021 May; 70(5):. PubMed ID: 33999797 [No Abstract] [Full Text] [Related]
5. Identification and partial characterization of Mycobacterium avium and Mycobacterium intracellulare by using DNA probes. Saito H; Tomioka H; Sato K; Tasaka H; Tsukamura M; Kuze F; Asano K J Clin Microbiol; 1989 May; 27(5):994-7. PubMed ID: 2745706 [TBL] [Abstract][Full Text] [Related]
6. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens. Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615 [TBL] [Abstract][Full Text] [Related]
7. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates. Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258 [TBL] [Abstract][Full Text] [Related]
8. Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS. Guthertz LS; Damsker B; Bottone EJ; Ford EG; Midura TF; Janda JM J Infect Dis; 1989 Dec; 160(6):1037-41. PubMed ID: 2584751 [TBL] [Abstract][Full Text] [Related]
9. In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method. Tomioka H; Saito H; Fujii K; Sato K; Hidaka T Antimicrob Agents Chemother; 1993 Jan; 37(1):67-70. PubMed ID: 8431020 [TBL] [Abstract][Full Text] [Related]
10. In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex. Hoffner SE; Kratz M; Olsson-Liljequist B; Svenson SB; Källenius G J Antimicrob Chemother; 1989 Sep; 24(3):317-24. PubMed ID: 2808189 [TBL] [Abstract][Full Text] [Related]
11. Differential drug susceptibility patterns of Mycobacterium chimaera and other members of the Mycobacterium avium-intracellulare complex. Maurer FP; Pohle P; Kernbach M; Sievert D; Hillemann D; Rupp J; Hombach M; Kranzer K Clin Microbiol Infect; 2019 Mar; 25(3):379.e1-379.e7. PubMed ID: 29906595 [TBL] [Abstract][Full Text] [Related]
12. Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014. Lee MR; Chien JY; Huang YT; Liao CH; Shu CC; Yu CJ; Hsueh PR Int J Antimicrob Agents; 2017 Jul; 50(1):35-40. PubMed ID: 28478210 [TBL] [Abstract][Full Text] [Related]
13. Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China. Zhang Z; Pang Y; Wang Y; Cohen C; Zhao Y; Liu C Int J Antimicrob Agents; 2015 May; 45(5):491-5. PubMed ID: 25795316 [TBL] [Abstract][Full Text] [Related]
14. In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates. Lin S; Hua W; Wang S; Zhang Y; Chen X; Liu H; Shao L; Chen J; Zhang W BMC Microbiol; 2022 Jul; 22(1):175. PubMed ID: 35804298 [TBL] [Abstract][Full Text] [Related]
15. Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan. Yamaba Y; Ito Y; Suzuki K; Kikuchi T; Ogawa K; Fujiuchi S; Hasegawa N; Kurashima A; Higuchi T; Uchiya KI; Watanabe A; Niimi A J Infect Chemother; 2019 Dec; 25(12):995-1000. PubMed ID: 31239192 [TBL] [Abstract][Full Text] [Related]
16. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system. Litvinov V; Makarova M; Galkina K; Khachaturiants E; Krasnova M; Guntupova L; Safonova S PLoS One; 2018; 13(9):e0203108. PubMed ID: 30222736 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility and molecular characterization of Mycobacterium intracellulare in China. Zhao X; Wang Y; Pang Y Infect Genet Evol; 2014 Oct; 27():332-8. PubMed ID: 25131955 [TBL] [Abstract][Full Text] [Related]
18. [Identification of Mycobacterium avium and Mycobacterium intracellulare using three DNA probe tests, and their distributions in Japan]. Tomioka H; Sato K; Saito H; Tasaka H Kekkaku; 1991 Nov; 66(11):739-46. PubMed ID: 1766154 [TBL] [Abstract][Full Text] [Related]
19. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to new macrolides, new quinolones, and antituberculous drugs on Dubos agar medium]. Ogawa K; Miwa T; Sasamoto M; Sasaki T; Tsuda M; Honda K; Furui H; Torii K; Takagi K Kekkaku; 1992 Nov; 67(11):735-8. PubMed ID: 1487866 [TBL] [Abstract][Full Text] [Related]
20. Distribution and clinical significance of Mycobacterium avium complex species isolated from respiratory specimens. Kim SY; Shin SH; Moon SM; Yang B; Kim H; Kwon OJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Koh WJ Diagn Microbiol Infect Dis; 2017 Jun; 88(2):125-137. PubMed ID: 28291631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]